IL-17 blockers

New class of psoriasis drugs being developed
Bloomberg
Fri, 10/4/13 - 10:14 am
psoriasis
Novartis
AstraZeneca
Amgen
Eli Lilly
Enbrel
secukinumab
brodalumab
IL-17 blockers